Recombinant monoclonal antibody to Abeta. Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-APP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-227)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Abeta. It is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1185z | Mouse Anti-APP Recombinant Antibody (clone 25F3) | WB, FC, ICC, IF, IHC | Mouse IgG1 |
PABL-010 | Mouse Anti-APP Recombinant Antibody (clone 12A11) | WB, IF, FuncS | Mouse IgG2a, κ |
HPAB-0346-FY | Mouse Anti-APP Recombinant Antibody (clone IBL-102) | FC, FuncS | Mouse IgG |
ZG-0306F | Mouse Anti-APP Recombinant Antibody (ZG-0306F) | WB, IHC, ELISA | Mouse IgG |
VS3-WK2020 | Rabbit Anti-APP (pT743) Recombinant Antibody (clone R07-4D0) | WB, ICC, IF, IP | Rabbit IgG |
There are currently no Customer reviews or questions for TAB-227. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.